Hepcdac (Daklinza) Daclatasvir 60mg online


In stock

Hepcdac(Daklinza)Daclatasvir 60mg


Hepcdac(Daklinza)Daclatasvir 60mg, is a hepatitis C virus (HCV) NS5A inhibitor indicated for use with sofosbuvir, with or without ribavirin, for the treatment of chronic HCV genotype 1 or 3 infection.
Limitations of Use: Sustained virologic response (SVR12) rates are reduced in genotype 3 patients with cirrhosis receiving Daclatasvir 60mg in combination with sofosbuvir for 12 weeks.
Hepcdac’s brand name is Daklinza by Bristol-Myers Squibb. Hepcdac is a generic oncologic prescription medicine from Cipla, which is one of the biggest pharmaceutical company in India.

Submit your review

Your email address will not be published. Required fields are marked *


There are no reviews yet.

See It Styled On Instagram

    Instagram did not return any images.

Main Menu